{"id":6030,"date":"2025-01-27T10:54:14","date_gmt":"2025-01-27T05:24:14","guid":{"rendered":"https:\/\/lakshmishree.com\/news\/?p=6030"},"modified":"2025-01-27T10:56:09","modified_gmt":"2025-01-27T05:26:09","slug":"review-of-dr-agarwals-health-care-ipo","status":"publish","type":"post","link":"https:\/\/lakshmishree.com\/news\/review-of-dr-agarwals-health-care-ipo\/","title":{"rendered":"Review of Dr. Agarwal’s Health Care Limited IPO : Lot Size, Check Issue Date, Price"},"content":{"rendered":"\n

Dr. Agarwal’s Health Care IPO Price: <\/strong>\u20b9382 to \u20b9402 per share
IPO Dates:<\/strong> 29 January 2025 – 31 January 2025<\/p>\n\n\n\n

\n
\n
\n
\n
\"Dr.<\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Company Overview<\/strong><\/h2>\n\n\n\n

Incorporated in April 2010 in Chennai, Tamil Nadu, Dr. Agarwal’s Health Care Limited is India\u2019s largest eye care service chain by revenue. The company offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceuticals.<\/p>\n<\/div>\n<\/div>\n\n\n\n

Operational Network and Reach<\/strong><\/h2>\n\n\n\n

As of September 30, 2024, the company operates 193 facilities across 14 states and four union territories in India, covering 117 metro and non-metro cities. This network is based on a hub-and-spoke model, consisting of 28 hubs (including three Centers of Excellence) and 165 spokes (53 primary and 112 secondary facilities). Internationally, the company has 16 facilities across nine African countries. Additionally, Dr. Agarwal\u2019s Health Care is recognized for its NABH-accredited facilities, with 29 accredited centers as of December 2024.<\/p>\n\n\n\n

Clinical and Operational Excellence<\/strong><\/h2>\n\n\n\n

The company is known for its end-to-end, comprehensive eye care offerings. It specializes in various super-specialties, including cataract, cornea, retina, refractive surgery, glaucoma, oculoplasty, and neuro-ophthalmology. By September 2024, 737 doctors were providing care across its facilities. During FY 2024, Dr. Agarwal\u2019s served 2.13 million patients and performed 220,523 surgeries. In the six months ending September 30, 2024, it served 1.15 million patients and conducted 140,787 surgeries.<\/p>\n\n\n\n

Key Services<\/strong><\/h2>\n\n\n\n
    \n
  1. Cataract Surgeries<\/strong>: The company offers advanced cataract treatments, including small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments.<\/li>\n\n\n\n
  2. Refractive Surgeries<\/strong>: These procedures aim to correct refractive errors and reduce dependence on glasses or contact lenses. Key options include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).<\/li>\n\n\n\n
  3. Other Surgeries<\/strong>: The company provides treatments such as surgical retinal procedures, corneal transplantation, pinhole pupilloplasty, oculoplasty, and surgeries for glaucoma and pterygium.<\/li>\n<\/ol>\n\n\n\n

    Market Leadership<\/strong><\/h2>\n\n\n\n

    Dr. Agarwal\u2019s Health Care holds approximately 25% of the total eye care service chain market in India as of FY 2024, with revenue nearly 1.7 times higher than the second-largest eye care chain.<\/p>\n\n\n\n

    Competitive Strengths<\/strong><\/h2>\n\n\n\n